|
Market Closed -
NYSE
02:31:58 12/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 470.90 USD | -0.97% |
|
+2.39% | +23.98% |
| 10/11 | Waters Says US FDA Clearance Obtained for Leukemia, Lymphoma Clinical Tests | MT |
| 10/11 | Waters Corporation Announces FDA 510(k) Clearance For BD OneFlow LST Test And BD OneFlow B-CLPD T1 Test | CI |
| Market Cap | 4.67TCr 4.21TCr 3.89TCr 3.52TCr 6.65TCr 4,38200Cr 6.82TCr 47TCr 19TCr 2,34700Cr 18TCr 17TCr 7,46800Cr | P/E 2026 * |
106x | P/E 2027 * | 42.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.08TCr 4.58TCr 4.23TCr 3.83TCr 7.24TCr 4,76600Cr 7.42TCr 51TCr 20TCr 2,55200Cr 19TCr 19TCr 8,12300Cr | EV / Sales 2026 * |
7.83x | EV / Sales 2027 * | 6.92x |
| Free-Float |
48.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WAT | Delayed | |
CBOE
| WAT | Real-time | |
|
Tradegate
| WAZ | Real-time | |
|
Börse Stuttgart
| WAZ | Delayed | |
|
London S.E.
| 0LTI | Delayed | |
|
Berne S.E.
| WAZ | End-of-day quote | |
|
Deutsche Boerse AG
| WAZ | Delayed | |
|
Boerse Muenchen
| WAZ | Real-time | |
|
Borsa Italiana
| 1WAT | End-of-day quote | |
|
Xetra
| WAZ | Delayed | |
|
Wiener Boerse
| WTRS | End-of-day quote |
Last Transcript: Waters Corporation
| 1 day | -0.97% | ||
| 1 week | +2.39% | ||
| Current month | +1.77% | ||
| 1 month | +8.56% | ||
| 3 months | +14.36% | ||
| 6 months | +32.60% | ||
| Current year | +23.98% |
| 1 week | 450.61 |  | 483.33 |
| 1 month | 422.82 | | 483.33 |
| Current year | 282.77 | | 483.33 |
| 1 year | 282.77 | | 483.33 |
| 3 years | 249.34 | | 483.33 |
| 5 years | 231.9 | | 483.33 |
| 10 years | 133.35 | | 483.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Udit Batra
CEO | Chief Executive Officer | 55 | 01/09/2020 |
Amol Chaubal
DFI | Director of Finance/CFO | 50 | 12/05/2021 |
Brook Colangelo
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/03/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 01/05/2006 | |
Flemming Ørnskov
CHM | Chairman | 68 | 01/01/2020 |
Linda Baddour
BRD | Director/Board Member | 68 | 01/09/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Free | Director | 57 | 0.0001% | ||
| 30/09/26 | Free | Director | 57 | 0.0001% | ||
| 06/08/26 | Exercice | Director | 10,878 | 0.0111% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | +2.39% | +25.05% | +84.00% | 4.67TCr | |
| -0.07% | +2.77% | +24.53% | +60.05% | 27TCr | |
| -0.34% | +2.26% | +11.43% | +19.45% | 17TCr | |
| -0.11% | +1.99% | -21.98% | +62.00% | 16TCr | |
| +0.96% | +3.75% | -55.28% | -12.47% | 6.48TCr | |
| +1.73% | +11.16% | +25.84% | +64.79% | 5.98TCr | |
| +1.35% | +0.39% | +0.37% | -8.59% | 5.33TCr | |
| -0.52% | +0.85% | +20.90% | +63.13% | 5.01TCr | |
| -0.26% | +0.51% | +3.05% | +84.62% | 4.95TCr | |
| -1.26% | +2.41% | +12.41% | +18.81% | 3.78TCr | |
| Average | -0.02% | +3.14% | +4.63% | +43.58% | 10TCr | |
| Weighted average by Cap. | -0.13% | +3.03% | +6.12% | +45.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 649.08Cr 585.02Cr 540.48Cr 488.6Cr 924.39Cr 61TCr 947.2Cr 6.48TCr 2.58TCr 33TCr 2.44TCr 2.38TCr 1,03800Cr | 716.6Cr 645.87Cr 596.71Cr 539.43Cr 1.02TCr 67TCr 1.05TCr 7.15TCr 2.85TCr 36TCr 2.69TCr 2.63TCr 1,14500Cr |
| Net income | 44Cr 40Cr 37Cr 33Cr 63Cr 4.17TCr 65Cr 443.83Cr 176.9Cr 2.23TCr 166.91Cr 163.37Cr 7.11TCr | 105.17Cr 95Cr 88Cr 79Cr 149.78Cr 9.86TCr 153.48Cr 1.05TCr 418.33Cr 5.28TCr 394.72Cr 386.33Cr 17TCr |
| Net Debt | 409.53Cr 369.11Cr 341.01Cr 308.27Cr 583.23Cr 38TCr 597.62Cr 4.09TCr 1.63TCr 21TCr 1.54TCr 1.5TCr 65TCr | 287.83Cr 259.42Cr 239.68Cr 216.67Cr 409.92Cr 27TCr 420.04Cr 2.87TCr 1.14TCr 14TCr 1.08TCr 1.06TCr 46TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $470.90 | -0.97% | 6,50,057 |
| 10/26/10 | $475.52 | -0.25% | 8,89,329 |
| 09/26/09 | $476.70 | +4.17% | 11,37,441 |
| 06/26/06 | $457.60 | +1.00% | 6,95,778 |
| 05/26/05 | $453.08 | -3.11% | 11,49,804 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WAT Stock
Select your edition
All financial news and data tailored to specific country editions
